Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance
Cholera Control in Endemic Regions of Africa: Clinical Surveillance and Cholera Shedding Study in the Context of Mass Vaccination Campaigns, Democratic Republic of the Congo
Sponsor: Epicentre
Listed as NCT04853186, this observational or N/A phase trial focuses on Cholera and remains actively recruiting participants. Sponsored by Epicentre, it has been updated 8 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Oct 2024 — Sep 2025 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Dec 2021 — May 2023 [monthly]
Recruiting
-
Jun 2021 — Dec 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Jun 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Epicentre
- Grand Labo de Lubumbashi
- Institut National de Recherche Biomédicale. Goma, République Démocratique du Congo
- Ministry of Public Health, Democratic Republic of the Congo
- Médecins Sans Frontières, France
- Wellcome Trust
For direct contact, visit the study record on ClinicalTrials.gov .